1. Home
  2. BSX vs DCOMP Comparison

BSX vs DCOMP Comparison

Compare BSX & DCOMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BSX
  • DCOMP
  • Stock Information
  • Founded
  • BSX 1979
  • DCOMP N/A
  • Country
  • BSX United States
  • DCOMP United States
  • Employees
  • BSX N/A
  • DCOMP 887
  • Industry
  • BSX Medical/Dental Instruments
  • DCOMP Major Banks
  • Sector
  • BSX Health Care
  • DCOMP Finance
  • Exchange
  • BSX Nasdaq
  • DCOMP Nasdaq
  • Market Cap
  • BSX 138.4B
  • DCOMP N/A
  • IPO Year
  • BSX 1992
  • DCOMP N/A
  • Fundamental
  • Price
  • BSX $102.17
  • DCOMP $18.89
  • Analyst Decision
  • BSX Strong Buy
  • DCOMP
  • Analyst Count
  • BSX 23
  • DCOMP 0
  • Target Price
  • BSX $110.57
  • DCOMP N/A
  • AVG Volume (30 Days)
  • BSX 10.4M
  • DCOMP N/A
  • Earning Date
  • BSX 04-23-2025
  • DCOMP N/A
  • Dividend Yield
  • BSX N/A
  • DCOMP N/A
  • EPS Growth
  • BSX 15.23
  • DCOMP N/A
  • EPS
  • BSX 1.37
  • DCOMP N/A
  • Revenue
  • BSX $17,554,000,000.00
  • DCOMP N/A
  • Revenue This Year
  • BSX $15.77
  • DCOMP N/A
  • Revenue Next Year
  • BSX $10.33
  • DCOMP N/A
  • P/E Ratio
  • BSX $74.56
  • DCOMP N/A
  • Revenue Growth
  • BSX 19.36
  • DCOMP N/A
  • 52 Week Low
  • BSX $70.97
  • DCOMP N/A
  • 52 Week High
  • BSX $107.17
  • DCOMP N/A
  • Technical
  • Relative Strength Index (RSI)
  • BSX 60.21
  • DCOMP 50.89
  • Support Level
  • BSX $92.70
  • DCOMP $18.37
  • Resistance Level
  • BSX $102.37
  • DCOMP $19.19
  • Average True Range (ATR)
  • BSX 3.26
  • DCOMP 0.79
  • MACD
  • BSX 1.11
  • DCOMP 0.05
  • Stochastic Oscillator
  • BSX 95.15
  • DCOMP 79.31

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

About DCOMP Dime Community Bancshares Inc. Fixed-Rate Non-Cumulative Perpetual Preferred Stock Series A

Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.

Share on Social Networks: